MELBOURNE, Australia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,”Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, ...

MELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study supports its success ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Genetic sequencing has gone through several advances. A major breakthrough came when scientists began breaking the billions of letters that compose DNA up into relatively small bits of a few hundred ...

Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer. Now, however, Yale scientists have ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Genetic Technologies ( ($AU:GTG) ) has issued an update. Genetic Technologies Limited announced the resignation of Mr. Mark Ziirsen as the Joint ...

The notion of tinkering with an embryo's DNA – let alone creating designer babies – makes many of us recoil. But let us not forget the shock and horror at the news of the first "test-tube baby," ...

A Canadian company is trying to make it possible for anyone to be a "biohacker" and make custom genetically modified organisms in their home kitchen. Homemade GMOs may sound scary to some, but Toronto ...

Yvonne Bombard is a genomics health services researcher at St. Michael's Hospital; Ronald Cohn is chief of pediatrics at the Hospital for Sick Children; Stephen Scherer is a genome scientist at the ...